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Preface
This PhD study was initiated in January 2007 and is based on human blood plasma
from a single meal study and an intervention study conducted at the Department
of Human Nutrition, Faculty of Life Sciences, University of Copenhagen (KU).
The experimental work was carried out at the National Food Institute, Technical
University of Denmark (DTU) and at the Department of Biochemistry and Biology,
Southern University of Denmark (SDU).
During my three years as PhD student, my main workplace has been DTU in
Lyngby, where I learned a lot about sample preparation, how to run two dimen-
sional electrophoresis, data processing and statistical analyses. I also spent half a
year at Department of Human Nutrition, KU, where I was the main co-ordinator
of the human single meal study. At this place, I gained valuable knowledge about
how to conduct human nutritional studies including recruitment of subjects, plan-
ning and performing the study. Moreover, with assistance from Rene Lametsch,
Department of Food Science, Faculty of Life Sciences, University of Copenhagen,
I also got insights into mass spectrometry based identification of proteins.
This thesis consists of two parts; part I describes the health beneficial effects of fish
intake in relation to the association between n-3 LCPUFA and decreased risk of car-
diovascular disease. Part II describes the applied proteomic methodology includ-
ing sample preparation, two-dimensional electrophoresis, data analysis and mass
spectrometry. The present PhD project was supported by grants from the Danish
Agency for Science, Technology and Innovation, and the Danish Food Industry
Agency.
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Summary
Substantial evidence indicates an association between diet and incidence of chronic
diseases. Thus, the development of biomarkers of predicting outcome for food
based studies is essential given insights into the metabolic and cellular response
induced by nutrients. Moreover, these biomarkers will provide knowledge on the
early diet induced changes of proteins that precede health benefits or the onset of
disease. However, the link between diet and disease is complex and difficult to
unravel.
The main methodology used in the present PhD study was proteome analysis (two-
dimensional gel electrophoresis), which is the study of the protein composition in
an organism at a given time. Proteome analysis of human blood plasma offers a
strong approach to increase the knowledge of the early dynamic changes in pro-
teins induced by dietary components. Furthermore, plasma proteins are a circula-
ting representation of body tissue thus reflecting the overall metabolic state of an
individual.
Based on a single meal study and an intervention study in healthy subjects, the aim
was to investigate acute and long-term effects of meal intake on the plasma pro-
teome profiling. We further aimed to examine the influence on consumers health
of replacing a marine based feed with one of vegetable origin for farmed trout. We
also assesed the largest variance component in the 2-DE data set from the single
meal study including different experimental parameters.
The results showed that single meal intake of trout compared to poultry elicited
postprandial responses in proteins linked to the biological processes lipid transport,
coagulation and complement cascade, acute phase response as well as cofactor
and vitamin metabolism. No differences were seen in the postprandial triacyl-
glycerol response after intake of trout compared to poultry. A daily meal of farmed
trout fed either on pure marine diet or pure vegetable diet, or a reference meal
of chicken for eight weeks induced changes in abundance of proteins implicated
in the various biological processes haeme transport and catabolism, regulation of
vasoconstriction, blood haemostasis, complement cascade, antioxidative defence,
cellular component movement, glycolysis and vitamin transport. However, only
a single protein identified as complement c1r differed significantly in the marine
fed trout compared to the vegetable fed trout. The individual variation represented
the largest variance component exceeding experimental parameters as fasting or
postprandial sampling, meal type (poultry, marine fed trout and vegetable fed trout)
and time (weeks).
This thesis demonstrated that 2-DE based proteomics is a powerful tool to detect
meal induced changes in plasma proteins. The individual variation is a significant
factor for comparative proteomic studies and needs to be taken into account in the
experimental design of human studies and interpretation of data. Furthermore, we
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have demonstrated that cross-over studies using an individual as its own control and
measure analyte variations over time is an important experimental design for study-
ing human plasma proteins due to large biological variation between individuals.
IX
Resume´
Proteomteknologi i ernæringsforskning − et 2-DE baseret studie af kostindu-
cerede ændringer i plasmaproteiner hos mennesker
Der er belæg for, at der er en sammenhæng mellem kost og forekomst af kro-
niske sygdomme. Udvikling af biomarkører til at forudsige effekter i forbindelse
med ernæringsstudier er derfor af væsentlig betydning, idet der herved opna˚s en
forsta˚else for de metaboliske og cellulære respons, som induceres af næringsstof-
fer. Desuden vil disse biomarkører give en indsigt i de tidlige kostinducerede pro-
teinændringer, som ga˚r forud for sundhedsgavnlige effekter eller sygdomsfrem-
brud. Sammenhængen mellem kost og sygdom er dog kompliceret og vanskelig at
forklare.
Den anvendte metode i dette PhD studie er primært proteomanalyse (todimensionel
gelelektroforese), som er studiet af ændringer og mønstre i proteinekspression i
en organisme pa˚ et givent tidspunkt. Proteomanalyse baseret pa˚ blodplasma fra
mennesker er en velegnet metode til at øge kendskabet til de tidlige dynamiske
kostinducerede ændringer, da cirkulerende plasmaproteiner repræsenterer vævet i
et individ og dermed afspejler den generelle metaboliske tilstand.
Forma˚let med dette studie var at undersøge akutte og langtidseffekter pa˚ proteom-
profilen i plasma efter indtagelse af ma˚ltider pa˚ baggrund af et enkelt ma˚ltidsstudie
samt et interventionsstudie med raske forsøgspersoner. Desuden undersøgte vi
betydningen af at erstatte marint baseret ørredfoder med vegetabilsk i forhold til
forbrugernes sundhed. Derudover vurderede vi hvilke eksperimentelle parametre
som bidrog til den største variation i et 2-DE datasæt fra enkelt-ma˚ltidsstudiet.
Resultaterne viste, at indtagelse af et enkelt ma˚ltid af ørred i forhold til fjerkræ
udløste forskellige postprandielle respons i proteiner, som er involverede i følgende
biologiske processer som lipid transport, koagulation- og komplement-kaskade,
akut fase respons samt cofaktor og vitamin metabolisme. Der blev ikke detek-
teret forskel i det postprandielle triglycerid respons efter indtagelse af ørred sam-
menlignet med fjerkræ. Et dagligt ma˚ltid besta˚ende af enten marint fodret ørred,
vegetabilsk fodret ørred eller fjerkræ (reference) gennem otte uger inducerede æn-
dringer i forekomsten af proteiner involveret i forskellige biologiske processer sa˚
som hæm-transport og katabolisme, regulering af vasokonstriktion, blod homeosta-
sis, komplement kaskade, antioxidativt forsvar, bevægelse af cellulære komponen-
ter, glykolyse og vitamin transport. Der var dog kun et enkelt protein, komple-
ment c1r, som ændrede sig signifikant efter indtagelse af den marint fodrede ørred
sammenlignet med den vegetabilske. Individ-forskelle bidrog til den største varia-
tion og overgik eksperimentelle parametre som faste eller postprandielle prøver,
ma˚ltidstype (fjerkræ, marint fodret ørred og vegetabilsk fodret ørred) og tid (uger).
Denne tese viste, at 2-DE baseret proteom-teknologi er et vigtig redskab til at de-
tektere ma˚ltids-inducerede ændringer i plasma proteiner. Individ-forskelle er af
Xstor betydning for proteomstudier og bør derfor tages i betragtning i forbindelse
med eksperimentelt design af humane studier og fortolkning af data. Vi har end-
videre vist, at anvendelse af overkrydsningsstudier, hvor hver forsøgsperson er sin
egen kontrol, er et vigtigt eksperimentelt design i studiet af plasma proteomet pga.
store biologiske forskelle mellem individer.
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1 Introduction
During the last decades, a considerable effort has been made in discovering, quanti-
fying and validating biomarkers. However, new and better biomarkers are urgently
needed to improve health and disease diagnosis in the general population. The
development of early, sensitive and accurate biomarkers for predicting outcome
of food based studies is becoming more and more important given substantial evi-
dence indicating an association between diet and incidence of chronic diseases [Hu
and Willett 2002; Van et al., 2008]. Yet, the link between diet and chronic disease
is complex and difficult to unravel [de Roos B. 2009].
The main methodology used in the present PhD study is proteome analysis based
on two-dimensional gel electrophoresis. This technique is powerful for the high
resolution separation of proteins in a complex mixture, thus providing a snapshot
of the protein composition in an organism at a given time. From the complex pro-
tein pattern it is possible to extract information of proteins, the key actors in vir-
tually all biological processes in the human body, changing in response to various
biological stimuli and responses such as diet or disease [de Roos B. and McAr-
dle 2008]. In this way, it is possible to increase the understanding of the dynamic
changes in proteins induced by dietary components, which may serve as candidate
biomarkers of health and thereby reveal early indications of disease risk [de Roos
B. and McArdle 2008; de Roos 2008]. However, the use of proteome studies in
nutritional science is still in its youth, but new investigations using this approach
will improve our molecular understanding of dietary induced health effects in hu-
mans and provide knowledge on the complex mechanisms of action [Kussmann
and Affolter 2009].
Human blood plasma represents an attractive and promising source for biomarker
discovery since it is easily accessible and is a circulating representation of all body
tissue reflecting the overall metabolic state of an individual [Anderson and An-
derson 2002; Jacobs et al., 2005; Nedelkov et al., 2005]. Despite its clinical im-
portance and huge amounts of investigations, major challenges exist for plasma
proteomic based biomarker discovery due to the huge dynamic range of plasma
proteins comprising more than 10 orders of magnitude [Anderson and Anderson
2002; Jacobs et al., 2005]. Furthermore, the human biological variability is a ma-
jor obstacle in clinical studies because it may mask the discovery of candidate
biomarkers and influence the proteins in a way that might enhance or degrade its
performance as biomarkers.
In Denmark, farmed fish contributes increasingly to the overall fish consumption
and the rainbow trout (Oncorhynchus mykiss), is a significant specie due to a high
annual production. Regular fish consumption and fish oil supplementation are as-
sociated with human health benefits, particular with regard to decreased risk of
cardiovascular disease (CVD) [Kris-Etherton et al., 2002]. These beneficial ef-
fects have been ascribed to the high content of the n-3 long chain polyunsaturated
2fatty acids (n-3 LCPUFAs), eicosapentaenoic acid (EPA) and docosahexaenoic
acid (DHA) in fish [Breslow 2006; Bucher et al., 2002; Kris-Etherton et al., 2002;
Wang et al., 2006a]. A further understanding of the underlying mechanisms of the
beneficial effects of fish intake will thus play a significant role for human health
due to the detection of early metabolic changes that precede the onset of CVD.
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2 Part I: Beneficial health effects of fish intake
2.1 Fish and health
Fish is considered one of the main components of a healthy diet. In Denmark,
official dietary guidelines concerning fish are expressed in one of the Eight Dietary
Advices from the Ministry of Food, Agriculture and Fisheries. The Danish public
is recommended to consume 200-300 grams of fish pr. week based on an evaluation
of the positive nutritional aspects relative to the potential toxic aspects. However, a
major cause of concern is the fact that fish is consumed in relatively small amounts
in western diets [Simopoulos 2006] including Denmark, in which fish consumption
is lower than recommended [Pedersen et al., 2010].
The interest and understanding of the health effects of fish and fish oil originate
from studies in populations consuming diets rich in n-3 polyunsaturated fatty acids
(n-3 LCPUFA). In the 1970s, Danish researchers reported beneficial lipid profiles
and a greatly lower incidence of CVD in coastal Greenlandic Eskimos consuming
a high fat diet rich in n-3 LCPUFA from fish and marine mammals as part of their
native lifestyle, compared to an equivalent Danish population [Bang and Dyerberg
1972; Kromann and Green 1980]. Similar effects of fish consumption were seen in
the Japanese population. The high fish intake in Japan, compared to Japanese men
living in Hawaii and California, was associated with a very low rate of myocardial
infarction and death from coronary heart disease (CHD). The incidence in Japan
was half that observed in Hawaii, and the highest rate was reported in Japanese
people living in California [Robertson et al., 1977]. These initial studies raised
considerable interest and led to the subsequent research interest on the role of n-3
LCPUFA in preventing and treating diseases, particular CVD, which is the leading
course of morbidity and mortality worldwide [Torrejon et al., 2007].
2.2 Polyunsaturated fatty acids metabolism and dietary sources
The n-3 and n-6 fatty acids are two families of polyunsaturated fatty acids (PUFA).
Alpha linolenic acid (ALA) and linoleic acid (LA), the precursors of n-3 and n-6
fatty acids respectively, cannot be de novo synthesised or inter-converted in the
human body and is termed nutritionally essential fatty acids. A sufficient intake
from food or other sources is essential for humans. In the body, ALA and LA
are converted and elongated to longer chained unsaturated fatty acid derivates (see
Figure 1) and the intermediates can either be incorporated into phospholipids or
become substrates for further elongation and desaturation processes [Russo 2009].
ALA is mainly derived from plants e.g. linseed and canola oil and major dietary
sources of LA are maize, sunflowerseed, safflowerseed and rapeseed oil, which are
used in many processed food products such as bread, cakes, biscuits and crisps
[Russo 2009; Schmitz and Ecker 2008].
4ALA can be converted in the liver to n-3 LCPUFA including the bioactive eico-
sapentaenoic acid (EPA) and docosahexaenoic acid (DHA) [Russo 2009]. Accor-
ding to a recent review [Burdge and Calder 2005], chronically increased ALA con-
sumption raised the EPA concentration but an insufficient conversion to DHA in
plasma and cell pools was seen. Overall, ALA appears to be a limited source of
n-3 LCPUFA [Burdge and Calder 2005]. Fish, especially oily fish such as mack-
erel, sardine, herring, salmon and trout, is a rich source of EPA and DHA. One
should note, that the content of these fatty acids also can vary considerable within
species dependent on season, fishing area as well as age and gender [Calder 2004;
Racine and Deckelbaum 2007]. EPA and DHA are incorporated into phospho-
lipids in most cell membranes in varying proportions and are released by phos-
pholipases. They are essential for many body functions in man such as growth
and reproduction [Lauritzen et al., 2001; Wathes et al., 2007]. Moreover, they
play a significant role in health status and can act via multiple pathways affecting
cell membrane function, eicosanoid metabolism and gene expression [Arab 2003;
Racine and Deckelbaum 2007]. EPA can be metabolised to eicosanoids of the
prostaglandin-3, thromboxane-3 and leukotrine-5 series [Schmitz and Ecker 2008].
The longer chained n-6 fatty acid arachidonic acid (AA) is derived from eggs, lard
and meat [Arab 2003; Russo 2009] and is the main precursor in eicosanoid synthe-
sis resulting in prostaglandin-2, thromboxane-2 and leukotrine-4 series. The dif-
ference between n-3 and n-6 PUFA derived eicosanoids is that mediators derived
from EPA and DHA exert most anti-inflammatory effects whereas those derived
from AA show mostly pro-inflammatory effects [Arab 2003; Schmitz and Ecker
2008].
The mechanisms whereby n-3 PUFA directly affects gene expression in different
tissue are complex and involve multiple processes, and the mechanisms remain
unclear [Deckelbaum et al., 2006; Sampath and Ntambi 2004]. N-3 PUFA has
been shown to modulate gene expression by regulating different transcription fac-
tors such as sterol-regulatory element binding protein (SREBP) and peroxisome
proliferator-activated receptor (PPAR). Both transcription factors are responsible
for regulating genes involved in lipid homeostasis; SREBP is a key regulator of
fatty acid, triacylglycerol and cholesterol synthesis and PPAR plays a role in lipid
oxidation and thermogenesis [Price et al., 2000; Sampath and Ntambi 2004].
2.3 Dietary ratio of n-6/n-3 PUFA
Since hepatic conversion of n-3 and n-6 PUFA to longer chained fatty acids shares
the same series of elongating and desaturating enzymes, a competition exists be-
tween those two families for biochemical metabolism of fatty acids with an excess
of one leading to a decrease in the conversion of the other [Schmitz and Ecker
2008]. Particular, the delta-6 desaturase is the rate-limiting enzyme and ALA and
LA compete for this enzyme in the synthesis of longer chained PUFA [Emken et
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Figure 1: Biochemical pathways for the metabolism of n-3 and n-6 PUFA.
Modified from [Schmitz and Ecker 2008]. LA: linoleic acid, AA: arachidonic acid,
ALA: a-linolenic acid, EPA: eicosapentaenoic acid, DHA: docosahexaenoic acid.
al., 1994]. Thus, the dietary n-3/n-6 PUFA ratio may have implications for func-
tional outcomes e.g. via changes in cell membrane properties, intracellular sig-
nalling, binding of n-3 LCPUFA to transcription factors or changes in bioactive
compounds [Calder 2007]. These outcomes are of importance for human health,
particularly in the pathogenesis of chronic diseases such as CVD [Russo 2009].
Major changes in our diet have taken place during the evolution from hunter-
gatherers to modern agriculture and a westernised life style, particularly in the
type and amount of essential fatty acids. During the last 150 years, a dramatic
increase is seen in human consumption of vegetable seed oils rich in n-6 fatty
acids with a parallel decrease in n-3 fatty acids. Thus, in the present western diet,
the ratio of n-6/n-3 PUFA can be as high as 20:1 compared to the diet of our an-
cestors probably being 1:1 or 2:1 [Simopoulos 2000; Simopoulos 2002]. A high
intake of n-6 compared to n-3 fatty acids will favour mediators of primarily pro-
inflammatory, pro-thrombotic and pro-aggregatory roles compared to those derived
from n-3 fatty acid metabolisms favouring the pathogenesis of chronic diseases (re-
viewed in [Simopoulos 2002]). Epidemiological studies have shown correlations
between the n-6/n-3 PUFA ratio in human diets and CVD. Thus, a lower ratio is
needed for prevention and management of CVD diseases, and the optimal ratio is
6varying with the disease of consideration [Simopoulos 2006]. However, it should
be noted, that beneficial effects of n-6 intake have been reported such as the well
described potential of LA to lower both total and LDL cholesterol in the blood and
to increase HDL-cholesterol [Kris-Etherton and Yu 1997].
2.4 N-3 LCPUFA and cardiovascular disease
Evidence from a meta-analysis based on randomised controlled trials and cohort
studies has shown that intake of fish or fish oil is associated with decreased risk
of cardiovascular disease and mortality both in CVD patients as well as people of
CVD risk [Bucher et al., 2002; Wang et al., 2006a]. In contrast, a meta-analysis by
Hooper et al., 2006 showed no effect of n-3 PUFA on cardiovascular events. The
reason for this inconsistency concerning the n-3 PUFA beneficial effects is likely
to be attributable to confounding factors such as health status of participants, espe-
cially since the Hooper analysis also included studies with healthy people, whereas
the Wang analysis were only based on studies with CVD patients. Furthermore,
the included studies differ in duration of follow-up time and most importantly type
of n-3 PUFA as the Hooper meta-analysis also focused on studies that supplied
alpha-linolenic acid, as well as source (dietary or supplemental) and dose admi-
nistered. These effects have been ascribed to the high content of n-3 LCPUFA in
fish [Bucher et al., 2002; Kris-Etherton et al., 2002; Wang et al., 2006a]. Nume-
rous effects of n-3 LCPUFA in relation to health have been reported and some of
the proposed mechanisms for the protective role of these fatty acids against car-
diovascular disease include lowered blood pressure [Geleijnse et al., 2002], altered
lipid profile; especially lowering of triacylglycerol [Harris 1996], reduced trom-
botic tendency [Robinson and Stone 2006], anti-inflammatory effects [Zampelas
et al., 2005], anti-arrhythmic effects including reduction in heart rate [Mozaffarian
et al., 2005] and improved vascular function [Chin and Dart 1995]. The plasma
triacylglycerol (TAG) lowering effects of n-3 LCPUFA are well established and
a reduction up to 30% is reported with effects seen in both normolipidemic and
hypertriglyceridemic patients, but with greater efficacy at higher triglyceride base-
line levels [Harris 1996]. Fish oil seems to have a small, dose-dependent effect
on blood pressure in hyper-cholesteromics and stable hypertensive people, though
no effects are seen on healthy subjects [Morris et al., 1993]. A meta-analysis has
shown that fish oil reduces heart rate particular in trials with a long treatment dura-
tion and with higher baseline heart rate [Mozaffarian et al., 2005]. Thus, beneficial
effects are mainly seen in older subjects with already high values of blood pressure
and heart rate.
Cohort studies have reported beneficial effects of n-3 LCPUFA, whereas others
studies have failed to detect these effects. The Nurses Health study including
85,000 women based on validated questionnaires reported a strong inverse associ-
ation of fish/n-3 LCPUFA intake and the incidence of all cause mortality through-
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out a 16-year follow-up period. Furthermore, the fatty acid-induced protection ap-
peared to be stronger for CHD death than for non-fatal myocardial infarction [Hu et
al., 2002]. In contrast, the US Physicians Health Study demonstrated no effects on
total myocardial infarction, non-sudden cardiac death or total cardiovascular mor-
tality in healthy men [Morris et al., 1995]. Likewise, the Health Professionals six
year follow up Study found no overall association between fish or n-3 LCPUFA
intake and the risk of coronary disease in men initially free of CVD, but a non-
significant trend toward lower risk of fatal CHD with increasing fish consumption
was seen [Ascherio et al., 1995].
The Gizzi-Prevenzione trial, a large secondary prevention trial, has investigated
the effect of dietary supplementation with n-3 LCPUFA in 11,000 patients with
a recent myocardial infarction. It was found that daily supplementation of one
gram of n-3 LCPUFA for two years reduced the occurrence of main cardiovas-
cular end points such as cardiovascular death, nonfatal myocardial infarction and
stroke by 20%, coronary or cardiac death and sudden death by 30%, and finally all
fatal events by 20% [Valagussa et al., 1999]. In the Japanese five year EPA sup-
plementation study (JELIS) conducted in more than 18,000 hypercholesterolemic
patients, documentation of a 19% reduction in major coronary events in the se-
condary prevention subgroup was seen [Yokoyama et al., 2007]. Results from the
30-year follow up of the Chicago Western Electric Study supported the evidence
that fish consumption favourably affects CHD mortality. Men, free of CVD, who
consumed at least 35 g of fish daily, had a 40% lower risk of fatal CHD, especially
non-sudden death from myocardial infarction [Daviglus et al., 1997].
In a recent meta-analysis, it was described that the effect of fish and fish oil intake
in terms of cardiac death is non-linear. Consumption of one to two servings of
fish pr.week, especially fish with a high content of n-3 LCPUFA, reduces the risk
of coronary death by 36% and total mortality by 17%. Moreover, little additional
protective effects were seen with increased fish intake above this level [Mozaffarian
and Rimm 2006].
Taken together, the above mentioned studies primarily support the growing body
of evidence that strongly suggests that consumption of n-3 LCPUFA has beneficial
effects on cardiovascular health. Thus, the American Heart Association, which
aims to improve diet and lifestyle to prevent CVD, recommends the general popu-
lation to eat fish, preferable a fatty fish meal at least twice a week and for those
people with known coronary heart disease to consume one g of EPA/DHA pr. day
preferably from fish or dietary supplement [Lichtenstein et al., 2006]. In addition
to providing EPA and DHA, however, it should be noted that fish consumption
may also lead to a decrease in consumption of other foods high in saturated fat and
trans-fatty acids.
82.5 Fish protein
Although the main focus of beneficial effects of fish intake according to preven-
tion and treatment of CVD has been related to the high content of n-3 LCPUFA,
fish is also an excellent source of other nutrients including high-quality proteins,
vitamin A, D and B, minerals and trace elements, especially iodine and selenium.
During a fish meal a significant amount of protein is consumed. Interestingly, the
possibility that fish protein, particularly amino acids, may contribute to the benefi-
cial health effects has emerged recently. Yet, only few studies have examined the
positive health effects of fish protein intake on health markers in humans as well
as in animal models of CVD. Ait-Yahia and colleagues have shown that a dietary
intervention of purified fish protein lowered blood pressure and decreased very low
density lipoprotein (VLDL)-TAG in hypertensive rats [Ait et al., 2005]. Additio-
nally, Boukortt et al. have shown a similar beneficial effect on blood pressure after
an intervention consisting of fish protein compared to casein in hypertensive rats
[Boukortt et al., 2004]. Furthermore, in normotensive rabbits, dietary fish pro-
tein induced a decrease in VLDL-TAG and a concomitant increase in high density
lipoprotein-cholesterol and lipoprotein lipase activity [Bergeron et al., 1991; Ber-
geron et al., 1992]. These results are of importance, since high blood pressure and
unhealthy lipid composition are contributors to development of CVD. Other studi-
es in rats have demonstrated that intake of protein from defatted cod fillets resulted
in improved glucose tolerance and insulin sensitivity [Lavigne et al., 2000; Trem-
blay et al., 2005]. A single cross-over study carried out in insulin-resistant men and
women has compared the effect of a four-week intervention with proteins from cod
compared with other animal proteins concerning their effects on insulin sensitivity
[Ouellet et al., 2007]. The consumed diets differed only in terms of protein source.
The intake of cod protein improved insulin sensitivity and had a strong tendency to
better the beta cell function. Moreover, data from this study showed that intake of
cod protein decreased plasma C-reactive protein levels [Ouellet et al., 2008]. These
findings may contribute to prevention of type II diabetes by reducing the metabolic
complications related to insulin sensitivity.
2.6 Fish farming and sustainability
In recent years, people in developed countries have been encouraged to increase
their intake of EPA and DHA from fatty fish to improve health and prevent deve-
lopment of major chronic diseases, especially CVD (see section n-3 LCPUFA and
cardiovascular disease). Given this overall interest in n-3 fatty acid consumption,
the decreased supplies will not be able to meet the increasing demand due to the
rapid worldwide decline of fish stocks. Even though the global catches of fish have
been on decline since the 1980s, the number of collapsed stocks has been increa-
sing exponentially since the 1950s consequently leading to the extinctions of ma-
rine populations in the worlds oceans [Jenkins et al., 2009]. Thus, the aquaculture
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sector aims at relieving the pressure on wild stocks of fish and thus compensates
for the shortfall of fish harvest by commercially raising farmed fish for human con-
sumption. Thereby, it has become the fastest growing food production sector of
the world and by 2010, more than 85% of global fish oil production is estimated to
be consumed in aquaculture feeds [Barlow 2000]. However, the issue is whether
the aquaculture industry really enhances or diminishes the available fish supply.
In aquaculture industry, carnivore fish species are grown on diets containing sig-
nificant amounts of fish meal and fish oil. These predators require approximately
2.5-5 times as much fish biomass as is produced and the carnivorous fish farming is
thus still perceived as a net fish consumer rather than a producer, which has raised
concern about the long-term sustainability of these industries [Naylor et al., 2000].
In that connection, great improvement has been made, since feed conversion ratio
values (ratio of the weight of feed added to the weight of fish produced) around
one is reported for several fish species [Mente et al., 2006].
Consequently, since wild fish is a finite value, substantial effort has been spent on
evaluating different feeding regimes as alternatives to fish meal and fish oils e.g.
ingredients of plant origin. The effect of a change in feeding regime from ma-
rine to vegetable based origin such as soy bean, lupin, peas and sunflower have
been proposed. Nevertheless, complete replacement of fish oil and protein in feed
for carnivore farmed fish faces several barriers. A change in feeding regime may
influence flesh and eating quality of the fish as well as nutritional properties e.g.
the content of n-3 LCPUFA. Thereby, the following consumption of these fish
may affect end-consumers health. Furthermore, plant ingredients contain different
anti-nutritional factors like protease inhibitors, phytates, lectins, anti-vitamins and
tannins, which present in varying degrees may have adverse effects in fish in rela-
tion to diet utilisation and digestibility and thus growth performance [Francis et al.,
2001]. Studies have shown that rainbow trout fed a diet composed of plant based
protein and oil was significantly affected according to sensory attributes of the fil-
lets such as smell, taste, texture, and colour compared to a marine based diet [de
Francesco et al., 2004; Skonberg et al., 1993]. In proteomic based studies of liver
proteins from rainbow trout, dietary replacement of fish meal with plant proteins
has shown to affect a number of metabolic pathways demonstrating the complex
nature of gene expression responses to dietary manipulations [Martin et al., 2003;
Vilhelmsson et al., 2004].
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3 Part II: Proteomics
3.1 Biomarkers and blood proteomics
A biomarker is a measurable indicator of a specific biological state, pathological
process and progress or pharmacological response to a therapeutic intervention [Ri-
fai et al., 2006; van Ommen et al., 2009]. The biomarker discovery process aims
at identifying proteins being up and down-regulated in association with a specific
biological process or disease state compared to healthy individuals [Kussmann and
Affolter 2009]. During the last decades, a considerable effort has been made in
discovering, quantifying, verifying and validating biomarkers. However, new and
better biomarkers are urgently needed to improve health and disease diagnosis. The
development of useful, sensitive and accurate biomarkers for predicting outcome
in food based studies is becoming more and more important given substantial evi-
dence indicating an association between diet and incidence of chronic diseases [Hu
and Willett 2002; Van et al., 2008]. Ideally, a biomarker of health should be able
to reflect the subtle but relevant molecular changes of food interventions in health
status that precede the onset of disease [van Ommen et al., 2009]. These early
biomarkers will give insights into the metabolic and cellular responses induced by
a nutrient and how it affects homeostasis in specific tissue within the whole orga-
nism. Moreover, they will provide knowledge on the early diet induced changes of
proteins that precede health benefits or the onset of disease.
Human blood plasma represents an attractive and promising source for biomarker
discovery due to several reasons. Blood is easily accessible in humans [Wang et
al., 2006b] and the plasma harbours tens of thousands of proteins that are synthe-
sised, secreted or lost from a variety of cells and tissue [Anderson and Anderson
2002; Jacobs et al., 2005]. Thus, the plasma proteome is a circulating representa-
tion of all body tissue reflecting the overall metabolic state of an individual [An-
derson and Anderson 2002; Jacobs et al., 2005; Nedelkov et al., 2005]. Despite
its clinical importance and huge amounts of investigations, major challenges exist
for plasma proteomic based biomarker discovery. Firstly, the complexity and the
sheer dynamic range of plasma protein concentrations, secondly, the relatively low
abundance of many proteins which are of biological and disease-specific interest
and thirdly, the inter-individual biological variation both in terms of physiologi-
cal and pathological variation between humans [Rifai et al., 2006]. Even though
the number of proteins detected in human plasma or serum is increasing rapidly,
a paradoxically decline is observed in the number of new protein biomarkers ap-
proved for use in clinical diagnostics [Anderson 2005a]. During the last decade,
the rate of introduction of new protein analytes approved by the US Food and Drug
administration has fallen to one biomarker pr. year [Rifai et al., 2006]. In fact,
only a handful of proteins are currently established in clinical use [Anderson and
Anderson 2002].
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3.2 History of proteomics
The term “proteomics” was first introduced in 1995 and defined as the large scale
characterisation of the entire protein complement of a cell line, tissue or an orga-
nism [Anderson and Anderson 1996; Wasinger et al., 1995; Wilkins et al., 1996].
Initially, the term was used to describe the study of the expressed proteins of a
genome using two-dimensional gel electrophoresis (2-DE) and mass spectrometry
(MS) for separating and identifying proteins. The scope of proteomics has broad-
ened considerably during the last decade and at present includes protein expression
profiling, protein function, protein modifications, protein localisation and compart-
mentalisation and protein-protein interactions [Graves and Haystead 2002]. This
rapid expansion of proteomics with increasing application to answer biological
questions is clearly reflected in the number of published papers and a literature
search conducted in Medline using the query “proteomics” gives 23849 hits. These
vast amounts of experimental data being gathered reveal that the proteome is more
complex than the genome. The total number of genes in the human genome is
24,000-30,000. If a given cell express 10,000 genes, the number of proteome com-
ponents in that cell may exceed 100,000 since one gene gives rise to a variety of
proteins through mechanisms extending from alternative splicing, proteolytic pro-
cessing to a wide range of posttranslational modifications [Kim et al., 2004].
Two-dimensional gel electrophoresis (2-DE) is still one of the most widely used
approaches in proteomics for identification of changes in proteins of tissue and bio
fluids [de Roos B. 2009]. The method is powerful for the high resolution sepa-
ration of proteins in a complex mixture, thus providing a snapshot of the protein
composition in an organism at a given time under a given condition. The classical
2-DE approach used in proteomics today based on the concept of combining iso-
electric focusing (IEF) and SDS-PAGE was initially introduced in the pre-omics
era in the mid-seventies by O’Farrell [O’Farrell 1975] and Klose [Klose 1975],
who began the mapping of proteins from E. Coli and mouse, respectively. They
made unforeseen contributions to the research field of proteomics and the appli-
cation of 2-DE to study cellular and tissue proteins from a global point of view
[Klose 2009; O’Farrell 2008]. In the first dimension, the IEF step, proteins are
separated according to electric charge (pI), whereas in the second dimension in-
cluding the SDS-PAGE, separation of proteins is based on their molecular weights.
The robustness of the methods has dramatically increased in nowadays mainly due
to the introduction of immobilised pH gradients improving the resolution and re-
producibility of protein separation in the first dimension [Bjellqvist et al., 1982]
and a drastically increased sensitivity of detected proteins by the introduction of
silver staining [Merril et al., 1981]. Moreover, the major breakthrough was the
development of micro-sequencing technologies in the beginning of the nineties in-
volving the identification of proteins of interest at first by Edman based sequencing
following the development and advances of MS and MS/MS based identification
of proteins [Aebersold and Mann 2003]. This greatly improved the quality of data
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obtained from 2-DE. More recently, the introduction of fluorescent staining has
further provided higher sensitivity and larger dynamic range compared to silver
staining [Steinberg et al., 2000]. Especially, the development of Difference Gel
Electrophoresis (DIGE), first described by Unlu et al., has greatly improved the
quantification of proteins in 2-D gels and allows for detection of subtle changes
in protein abundance [Unlu et al., 1997]. The inter-gel variation is substantially
eliminated by running three samples, marked with different fluorophores, on the
same gel.
3.3 Sample preparation of human plasma for 2-DE
Sample preparation is of utmost importance and very critical to acquisition of high
quality data from proteome analysis based on 2-DE. Preparation should be as sim-
ple as possible to increase reproducibility of the experiment. The main purpose
of sample preparation is to solubilise the proteins making them suitable for 2-DE
analysis, while minimising the loss of proteins during the procedure. The solubili-
sation process includes denaturation of the protein to break non-covalent bindings
within and among the proteins, while maintaining the native charge and molecular
weight of soluble proteins. Ideally, the perfect solubilisation mixture should freeze
all the proteins in their exact state both in terms of amino acid composition and
posttranslational modifications [Rabilloud 1999].
A large number of standard protocols are available, but these protocols have to
be adapted and optimised for the type of sample e.g. body fluids, tissue extracts
and microbial cells to be analysed. The following section will focus on the sam-
ple preparation procedures of human plasma, since it is used in the present PhD
study and is a highly complicated specimen to analyse by 2-DE. Figure 2 illu-
strates the flow diagram of sample preparation of plasma. Blood is collected in
tubes containing anticoagulants to prevent blood clotting. Different anticoagulants
have different molecular mechanisms, which are reflected in the proteome profile.
In a study by Hsieh et al., the addition of anticoagulants including heparin, EDTA
and sodium citrate was shown to have an impact on the following plasma proteome
profiling on the basis of whole MALDI-TOF spectra [Hsieh et al., 2006]. More-
over, the time-lag before separation of plasma from whole blood is very critical for
the analytic stability and the following proteome profiling due to cellular elements;
platelets in particular, can secrete a variety of cellular components. Therefore, in
the present PhD study plasma was prepared directly after blood collection to mini-
mise pre-analytical effects.
Addition of protease inhibitor cocktails have extensively been used in order to pre-
vent degradation of proteins that otherwise will result in artefactual spots on the
2-D gel and loss of high molecular weighted proteins. However, protease inhibitors
are not always recommended since they may modify protein structures and induce
changes in the charge of the molecules [Kim and Kim 2007] and may interfere with
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the MS based identification of proteins of interest. TCA/acetone mediated pre-
cipitation of proteins is useful to minimise protein degradation by proteases [Gorg
et al., 2004]. In addition, it has been shown that urea, thiourea and CHAPS in
combination are very effective inhibitors of proteolytic activity [Castellanos-Serra
and Paz-Lago 2002].
The major problem concerning the visualisation of plasma proteins is the broad
and dynamic range of proteins comprising more than 10 orders of magnitude [An-
derson and Anderson 2002; Jacobs et al., 2005], which really poses a challenge
for proteomics. The steep dynamic range begins with the core plasma protein, al-
bumin, which comprises approximately 50% of plasma protein content (45mg/ml)
and ends with circulating cytokines present at 1-10pg/ml [Anderson and Anderson
2002; Jacobs et al., 2005]. Therefore, sub-fractionation of plasma is a requisite to
simplify the protein composition of the plasma sample and to reach the lesser abun-
dant proteins. Strategies that often have been used to overcome this problem are
to fractionate the proteome into smaller sub-sets. Multiple approaches have been
used to simplify the plasma proteome including affinity, size and antibody based
depletion of high abundance proteins [Kim and Kim 2007]. Removal by immuno-
affinity capture is the most commonly used approach because of advantages of the
highly selective depletion process and the low cross-reactivity to non-target pro-
teins [Crosley et al., 2009; de Roos 2008; Jenkins et al., 2008]. In the present PhD
study, plasma was fractionated by an IgY-12 antibody based spin column (Beck-
man Coulter, CA) in accordance with the manufacturers instructions to remove the
top 12 high abundance proteins. These proteins make up less than 0.1% of the total
number of proteins present in plasma, yet they comprise up to 95% of the total
protein concentration in plasma [Huang et al., 2005]. Desrosiers and co-workers
[Desrosiers et al., 2007] have compared the efficiency of IgY-12 column with two
other columns removing two and six of the high abundance proteins, respectively.
They showed that the IgY-12 column was most efficient in enriching less abun-
dant proteins. This sub-fractionation of plasma will allow better resolution and
higher sensitivity required to detect the lower abundant plasma proteins compared
to crude plasma and thus increases the possibility to “dig” deeper into the human
plasma proteome. However, the principal disadvantage of antibody based deple-
tion includes its relatively high cost and low sample capacity. Moreover, a potential
artefact to be aware of includes non-specific binding to the column caused by the
ability of high abundant proteins, like albumin, to act as carrier protein for pep-
tides and protein fragments [Desrosiers et al., 2007; Elrick et al., 2006]. The 2-DE
based plasma protein profiling of human plasma before and after IgY-12 treatment
depleted of the top 12 high abundance proteins is shown in Figure 3. It is clearly
seen that the high abundance proteins contribute to a lot of smear in gel 3A. Re-
moval of these proteins enables detection of the lower abundant proteins seen in
gel 3B, and the result is a gel of distinct and separated spots.
2-DE based analysis of human plasma is rather difficult due to the many com-
ponents in the sample that bind with proteins and possibly interfere during the
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Figure 2: Flow diagram of the sample preparation procedure of plasma for
2-DE analysis.
analysis. Thus, removal of interfering substances is a prerequisite to 2-DE if their
amounts exceed a critical interference threshold. Contaminants in the sample pri-
marily include lipids, salts, polysaccharides and nucleic acids. Plasma turbidity
is normally caused by the lipids (TAG, phospholipids and sterols) in the sample,
which is highly present if sampling is conducted after meal intake. Lipids can
interfere with the depletion procedure, the IEF current in the first dimension and
the 2-DE resolution [Kim and Kim 2007]. The removal of lipids can be accom-
plished by the use of a solubilisation buffer containing a strong denaturing agent
[Jiang et al., 2004]. During first dimensional electrophoretic separation, salt ions
can interfere with the focusing of proteins and the time required for proteins to
reach a steady state will be prolonged [Gorg et al., 2004; Kim and Kim 2007]. De-
salting can be achieved by TCA and acetone precipitation, which was used in the
present sample preparation of human plasma. However, this may result in protein
losses due to incomplete precipitation and insufficient re-solubilisation of proteins.
Polysaccharides and nucleic acids may interact with carrier ampholytes and pro-
teins, which are capable of giving rise to streaky patterns in the 2-DE gel. A com-
mon method used to minimise the influence of these molecules, is to precipitate
proteins based on TCA and acetone [Gorg et al., 2004].
Prior to 2-DE, the sample has to be reduced, denatured, disaggregated and so-
lubilised to completely disrupt molecular interactions (disulfide bridges and non-
covalent interactions including ionic bonds, hydrogen bonds and hydrophobic in-
teractions) under conditions compatible with IEF. Addition of excess reducing
agents is necessary for cleavage of intra and intermolecular disulfide bonds so pro-
teins completely can unfold. Dithiothreitol (DTT) is one of the most frequently
used reductants [Gorg et al., 2004]. However, one should be aware of that DTT
is charged at alkaline pH and therefore is still not a perfect reducing agent. Some
proteins of high cysteine content or high cysteine reactivity are not fully reduced
by DTT, but addition of phosphines, which are uncharged reducing agents, can
solve the problem [Rabilloud 1999]. It has been reported that tributyl phosphine
may be more effective with protein samples that are difficult to solubilise [Herbert
et al., 1998]. However, problems concerning stability and solubility of this reagent
in aqueous solution are present.
Protein denaturation achieved by addition of chaoptropic agents like urea and thi-
ourea is widely used in sample preparation for 2-DE due to their efficiency for
solubilising proteins, as opposed to urea alone. Urea is quite efficient in disrupting
hydrogen bonds while thiourea is more suitable for breaking hydrophobic interac-
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tions. Additional detergents such as CHAPS are commonly included in the solu-
bilisation mixture due to its efficiency for solubilising hydrophobic proteins [Gorg
et al., 2004].
Figure 3: 2-DE based plasma protein profiling of human plasma before
and after IgY-12 treatment. In the first dimension, proteins are separated
according to electric charge in an immobilised pH gradient of pH 4-7, whereas in
the second dimension, proteins are separated according to their molecular weights
in a 12% SDS-PAGE gel. A: Un-fractionated human plasma, B: Human plasma
protein fraction after IgY treatment depleted of the 12 most abundant proteins.
3.4 First dimensional electrophoresis
The first dimension of 2-DE consists of isoelectric focusing, where proteins are
separated on basis of their charge. The isoelectric point (pI) of a protein is the
pH value of the proteins surroundings at which the protein has a zero net charge.
Carrier-ampholyte (CA) generated pH gradient was originally used in the first
2-DE protocols introduced by O’Farrell and Klose in 1975 [Klose 1975; O’Farrell
1975], but the method suffers from several limitations including resolution, re-
producibility, separation of very acidic and/or very alkaline proteins and sample
loading capacity [Weiss and Gorg 2009]. In order to overcome the limitations of
CA, immobilised pH gradients (IPG) was developed by Bjellqvist [Bjellqvist et al.,
1982] and further improved by Gorg and colleagues [Gorg et al., 1988]. To achieve
high resolution 2-DE patterns, the classical IEF protocol was modified taking into
account that IPGs behave differently compared to CA generated pH gradients. This
new separation technique greatly improved the resolution and it was the beginning
of a long journey of stepwise improvements of the 2-DE technology. Consequently,
IPG is nowadays the current method of choice in IEF of 2-DE in proteome analysis
[Gorg et al., 2009]. The IPG gradient is immobilised due to covalent anchoring
of the pH gradient to the acrylamide matrix during casting, which generates an
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extremely stable pH gradient. This leads to true steady state IEF with high re-
producibility due to constant zone position and pattern constancy and elimination
of batch differences as observed with CA [Gorg et al., 1988; Righetti and Bossi
1997]. IPG can be cast in different ranges between pH 2.5-pH 12 in both narrow
or wide ranges [Gorg et al., 2004] and the choice of range is dependent on sample
complexity and scientific purpose. Temperature during IEF has a significant effect
on the 2-DE pattern, since the position of protein spots on the gel vary along the
pH gradient, when different temperatures are applied. Thus, to achieve high repro-
ducibility of 2-DE gels, it is very important that IEF is conducted under a defined
temperature, where 20◦C has been shown to provide optimal conditions [Gorg et
al., 1991].
3.5 Second dimensional electrophoresis
Following the separation of proteins by first dimensional IEF, the second dimen-
sion is carried out by SDS-PAGE in an electric field, where proteins are separated
according to their molecular weights. SDS is an anionic detergent and disrupts
hydrogen bonds, blocks hydrophobic interactions and partly unfolds the protein.
It gives the proteins the same net negative charge per unit mass overwhelming the
native charge of sample proteins. Thus, during electrophoresis the denatured SDS
polypeptides are separated in the gel solely based on their molecular mass.
SDS-PAGE in second dimension can be performed on horizontal or vertical sy-
stems. The horizontal system is suited for pre-cast commercial gels but has li-
mited capacity of only a single gel, whereas the vertical system used in the present
PhD study is the system of choice for multiple runs in parallel, particularly for
large-scale analysis which requires simultaneous batch electrophoresis to increase
through-put and maximise reproducibility [Anderson and Anderson 1978]. The
most commonly used buffers for 2-DE is the discontinuous buffer system by La-
emmli [Laemmli 1970]. Altering the amount of acrylamide will affect pore size
and thus the sieving properties of the polyacrylamide gel. Nevertheless obtaining
high-quality separation of the entire molecular weight range of the sample proteins
remains an art, as differences can arise from a number of factors during the process.
The result of 2-DE analysis is a protein map of spots that are assigned their x
and y coordinates. Proteins are recognised according to their specific coordinates
and each spot represents one to few proteins depending on the complexity of the
sample. High resolution 2-DE can potentially resolve up to 10,000 protein spots
simultaneously [Zimny-Arndt et al., 2009] and from the complex protein profile
pattern it is possible to extract information about changes in protein expression
levels, isoforms or posttranslational modifications.
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3.6 Visualisation of proteins
After conducting 2-DE, the separated proteins in the gel have to be visualised,
as the main purpose of differential proteomics is to study the changes in expres-
sion level/amount of proteins. It is important that the visualisation approach meets
the acquirements of high sensitivity (low detection limit), high linear dynamic
range (quantitative accuracy) and compatibility of post-electrophoretic identifica-
tion methodologies such as mass spectrometry. However, currently no staining
method for proteome analysis fulfils all these criteria [Gorg et al., 2004]. The visua-
lisation of proteins can be obtained by application of various staining techniques
including organic dye, silver stain, reverse stain, fluorescent stain, radio-labelling
and chemiluminescent stain [Patton 2002]. Conventional Coomassie Brilliant Blue
is one of the most widely used dyes for 2-DE protein staining due to low cost,
ease of use and good compatibility with downstream protein identification me-
thods such as mass spectrometry. The principal limitation of this dye is insufficient
detection sensitivity, hence it is not able to stain low abundance proteins. It is
based on end-point staining with a detection limitation of 10-100 ng protein per
spot. Additionally, the dye provides a linear dynamic range of 10-30 fold of pro-
tein concentration [Weiss et al., 2009; Wu et al., 2005].
Silver staining is a frequently used approach for visualisation of 2-DE separated
proteins. It is sensitive and permits detection of the low nanogram level (0.5-1
ng of protein) but with a restricted linear dynamic range of only 10 fold concen-
trations. In contrast to Coomassie, silver stain is a quite complex procedure with
carefully controlled multi time-steps and staining development must be stopped at
some arbitrary time point in order to avoid saturation effect [Wu et al., 2005]. Con-
sequently, gel-to-gel reproducibility can be problematic. The most sensitive silver
stains are MS incompatible since aldehydes in the fixatives irreversible cross-link
polypeptide chains. However, alternative silver staining protocols have been de-
veloped that are compatible with MS based protein identification [Shevchenko et
al., 1996; Wu et al., 2005]. Generally, the modified technique is poorer in terms of
detection sensitivity and background staining is less uniform [Patton 2002].
Fluorescence staining of proteins is gaining popularity due to high sensitivity,
broad dynamic range and ease of use. On the other hand, the cost of the method is
quite high due to expensive chemicals and instruments needed for the detection of
fluorophores. The most common used fluorescence stain is non-covalently bound
fluorescence dye, such as Sypro Ruby, a ruthenium based metal chelate stain that
binds to basic amino acids in proteins and was originally developed for detection of
proteins in SDS-PAGE gels and proteins blotted to membranes [Wu et al., 2005].
The detection sensitivity (1 ng of protein) is as high as silver staining and the linear
dynamic range is at least three orders of magnitude exceeding Coomassie Brilliant
Blue and silver stain in terms of performance. Furthermore, it allows one-step end-
point staining and it can thus be performed over night without overdeveloping and
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concomitantly with low background staining [Ahnert et al., 2004; Patton 2002].
Finally, most procedures are compatible with protein identification methods such
as mass spectrometry [Gorg et al., 2004].
In the present PhD study, three different types of staining to visualise human
plasma proteins were compared; Coomassie Briliant Blue, Sypro Ruby and sil-
ver staining shown in Figure 4, respectively. By manual inspection, it is clearly
demonstrated that the approach based on silver staining is by far the most sensi-
tive staining technique to visualise the proteins. However, one should be aware
of the drawbacks of this staining method mentioned above. The low sensitivity of
Coomassie Brilliant Blue is also clearly confirmed even despite the fact that the
sample is four times as concentrated. Therefore, the staining of plasma proteins in
the enclosed papers is carried out by use of silver staining.
Figure 4: Visualisation of proteins. Plasma proteins are visualised on 2-DE gels
by use of (A) Coomassie, (B) Sypro Ruby and (C) silver staining.
3.7 Image analysis
After protein staining, it is of vital importance that protein spots are aligned ac-
curately to ensure high quality data from proteome experiments. One of the key
limitations for 2-DE based studies is the lack of a rapid, robust and reproducible
method for gel image analysis in terms of detecting, matching and quantifying
spots. To facilitate rapid and accurate image analysis with relatively high through-
put, a number of commercial software packages are available for image analysis
of 2-DE gels e.g. Delta 2D, Melanie, PDQuest, Image Master 2D Elite and Pro-
genesis [Raman et al., 2002]. These are based on different detection and match-
ing principles and have a broad range of options, capability and price. However,
all software packages use the same traditional workflow involved in differential
image comparisons analysis; (i) spot detection, (ii) gel-to-gel matching and (iii)
spot quantification [Raman et al., 2002]. Yet, manual editing during the spot detec-
tion is nearly impossible to avoid due to sample complexity with several thousands
of spots on a gel and mismatches must be carefully checked and edited e.g. dele-
tion of false protein spots and correction of spot shape. Even a very experienced
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person will not be able to produce gels with similar spot patterns. Dissimilarity
of spot positions in the 2-DE gel may be caused by variations in pH of running
buffer, incomplete polymerisation, current leakage, air bubbles in gels and influ-
ence of high abundant proteins on the pH gradient in IPG gels caused by their own
locally concentrated buffer capacity [Berth et al., 2007]. Slight variations in pro-
tein load pr. gel and staining efficiency can have a considerable impact on the raw
spot volumes. Hence, spot volume normalisation, a necessary step in 2-DE data
acquisition to minimize the analytical variation caused by gel-to-gel variations, is
very important for quantification of spot volumes.
Thus, it is important to stress, that even with the best performing program it is not
possible to extract good results from bad gels. Thus, 2-DE gels of good quality are
a prerequisite for high-quality image analysis and it is important to avoid experi-
mentally caused artefacts (background, noise and streaking), which will influence
the spot detection and quantification process.
3.8 Data analysis
In 2-DE based proteomics, large amounts of high dimensionality data are produced
due to the detection of hundreds or even thousands of protein spots. Generally, data
is divided in two groups, treatment versus control group, and spots are commonly
tested individually by use of univariate statistics such as the Students t-test to re-
veal spots changing in abundance between the two groups [Biron et al., 2006]. The
variation in spot volumes is heterogeneous; some spots differ highly in volume,
while others show only small differences. Consequently, data deviating from nor-
mal distribution is not uncommon. Often, data analysis is based on Students t-test
but the normal distribution of data is frequently assumed and not tested [Wilkins
et al., 2006]. Overall, inappropriate use of Students t-test or analysis of variance
(ANOVA) may result in a number of false positives spots, which is the case in seve-
ral proteomic studies, and this needs to be taken into consideration in the evaluation
of the data. Multiple testing correction methods exist (Bonferroni correction and
False Discovery Rate (FDR)) to adjust the values of protein spots based on Students
t-test or ANOVA to keep the overall rate of error as low as possible. An extension
of FDR is the q-value, which is the expected proportion of false positives incurred
among a set of significant findings changing in expression [Storey and Tibshirani
2003]. For each given p-value, a q-value can be reported and an overall estimate
for the proportion of protein species changing in abundance.
Using univariate statistics alone, it is impossible to reveal all the complex interac-
tions in protein expression profiling, and essential data information as well as data
structure is lost in the analysis. In multivariate statistical analysis e.g. principal
component analysis (PCA) and Partial Least Squares Regression (PLSR), all spots
are analysed simultaneously and this method offers a strong approach for the eva-
luation of 2-DE maps to get an overview of the main variation and structure in data
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[Jensen et al., 2008; Karp and Lilley 2007]. PCA is a multivariate pattern recog-
nition method breaking down the data matrix into systematic variation and noise.
PCA results in the decomposition of raw data into scores, describing the relation-
ship between samples, and into loadings showing the relationship between vari-
ables [Marengo et al., 2007]. The variation is described by principal components
(PC1, PC2, PC3 etc,), where the first PC explains the maximum possible variance
in the data set and each successive component account for the remaining residual
variance. The PCs are then calculated hierarchically, so experimental noise and
random variation are contained in the last PCs [Marengo et al., 2007; Marengo et
al., 2008]. Of course, this is only true, if experimental noise and random variations
represent a minor contribution compared to the systematic variation in data. An
example of PCA analysis of data from 2-DE based proteomics is demonstrated in
Figure 5. The proteome data is obtained from the single meal study in which hu-
man plasma samples were collected before meal intake and during the postprandial
phase. From the 2-DE based data, it is demonstrated that samples are grouped, to
a more or less extent, according to each subject and the inter-individual variation
thus represents a major variance component in the data.
Another very useful multivariate statistical approach is PLSR. By use of this re-
gression method it is possible to identify the relation of variation between two sets
of data (x and y data matrix), e.g. spots compared to other characteristics of the
samples. The result of the PLSR analysis is a prediction model, where the varia-
tion in the total spot dataset (x-variables) is used to explain the variation in other
measurements or related information of the same samples (y-variables).
3.9 Mass spectrometry based identification of proteins of interest
The classical 2-DE based approach coupled with spot identification by mass spec-
trometry has become the most widely used approach in proteomics to effectively
identifying the protein spots of tissue, cells and bio fluids [Fuchs et al., 2005; Roep-
storff 1997]. Various proteome maps with identified proteins originating from
different phyla, tissue and bio fluids are available on the internet at the Swiss-
2D-PAGE site (www.expasy.org/swiss-2dpage/viewer) with a constantly increa-
sing number of identified protein spots. A huge development of MS based tech-
nologies both in relation to instruments and computational protein analysis tech-
niques has enhanced the sensitivity and through-put of identification of 2-DE se-
parated proteins [Gygi and Aebersold 2000; Poutanen et al., 2001]. Furthermore,
the sequencing of several genomes, including the human genome, has been a great
advantage in MS based identification of proteins [Roepstorff 1997].
Mass spectrometry enables structural information such as exact peptide masses
and amino acid sequences, which makes it possible to identify proteins of interest
[Graves and Haystead 2002]. Different methods have been developed for identifi-
cation of proteins from 2-DE gels. Basically, fingerprints of proteins are created by
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Figure 5: PCA Scores plot of 2-DE separated human plasma proteins
derived from the single meal study. The PCA scores plot displays the first
three principal components in which PC1 (23%), PC2 (8%) and PC3 (6%) account
for 37% of the total variation in the data set.
in-gel digestion of proteins by a specific protease e.g. trypsin following a record-
ing of a mass spectrometric peptide map with information of experimental pep-
tide mass-to-charge value. Comparing the experimentally obtained mass against a
theoretical obtained mass data from an already identified protein in a database leads
to protein identification. The work presented in this thesis is based on MS/MS re-
sults obtained from Maldi/Tof-Tof mass analyser, which is a classical approach and
commonly used for identification of proteins from 2-DE. Maldi-MS is a sensitive
method and normally used to analyse relative simple peptide mixtures, like in this
case a protein excised from a 2-DE gel, contrary to liquid-chromatography elec-
tro spray ionisation MS systems, which are ideal for analysis of complex samples
[Abersold and Mann 2003]. Additionally, Maldi-MS is more tolerant to contami-
nants like salts and small amounts of detergents, which may appear in the excised
protein spots from the 2-DE gel [Domon and Aebersold 2006]. Having determined
the mass-charge value and intensity of all the peptides in the MS spectrum, the
mass spectrometer proceeds to obtain sequence information about these peptides
by further fragmentising single selected peptide ions. The MS/MS spectrum is
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the result of an ensemble of one particular precursor ion fragmented at different
amide bonds and short amino acid sequence tags are generated for the individual
peptides. These partial sequences are compared to the original peptide masses of
all known proteins within the database, which greatly improves specificity [Steen
and Mann 2004]. Various peptide mass search programs are available on the Inter-
net e.g. Mascot, MS-fit and PeptideSearch [Kim et al., 2004] and the complexity
of the algorithms used to search sequence databases is program dependent. When
conducting large-scale studies with following identification of proteins by database
searching, one should use an organism with sequenced genome; so that all possible
peptides are known and time consuming de novo sequencing is thus not mandatory.
The Mascot MS/MS-search (www.matrixscience.com) is used for database search-
ing, where different MS variables e.g. instrument, taxonomy, database, enzyme
and modifications etc. are typed in prior to the search. Figure 6 shows a Mascot
report from a database search using a Maldi-Tof/Tof spectrum of a trypsin-digested
spot from a 2-D gel containing human plasma proteins. In this case, peptides gain-
ing a Mascot score greater than 27 are found significant (p<0.05). However, it
should be noticed that the significance limit is database dependant due to number
of entries. A single protein was significantly identified as retinol-binding protein
4 with a score of 281, which is highly trustworthy. The retinol-binding protein hit
has a sequence coverage of 29%, which is defined as the ratio of the portion of
the protein sequence covered by the matched peptides to the whole length protein
sequence.
The accuracy of the mono-isotopic mass is limited by the instrument used. Today,
by use of modern instruments, mass accuracy lower than 50 ppm is routine [Barnes
and Kim 2004]. In paper I, protein identifications are based on 2-5 peptides with a
mean mass accuracy of 7 ppm. Ideally, one would expect to observe a signal for all
peptides and whole sequence coverage of the protein. However, this is hardly ever
the case. Some proteins had an experimental molecular mass, estimated from the
spot position on the 2-DE gel, differing from the theoretical molecular mass. This
indicates that the analysed proteins were a fragment of their respective full length
proteins. Furthermore, this was clearly documented in the mascot report by look-
ing at the original amino acid sequence, where the matched peptides were found
for instance at the C-terminal end of the sequence with resulting low sequence co-
verage, since the calculation is based on the full length protein. From time to time
a spot contains a mixture of proteins. When a single protein in the spot is identi-
fied, additional proteins can be identified by doing a “second pass” search meaning
that after a correct identification of the first protein, the unmatched peptides can be
used in a new search. This feature is offered by the search engine Mascot.
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Figure 6: Mass spectrometry based identification of proteins. MS/MS based
Mascot search results of a spot exised from a 2-DE gel.
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3.10 Experimental design and biological variability
Randomised controlled trials (RCT) are considered as gold standard in human stu-
dies, when evaluating the efficacy and safety of a treatment intervention [Silver-
man 2009]. In these trials, subjects are randomised into different parallel treatment
groups and each group receives a specific treatment. They are simpler in experi-
mental design and more feasible compared to cross-over studies [Lathyris et al.,
2007]. In a cross-over study, each individual receives two or more treatments, but
in a random order. These studies represent relatively complex study design and it
can be difficult to apply for many research questions [Lathyris et al., 2007]. The
particular strength of a cross-over study is that the different treatments are evalu-
ated on the same subject, allowing comparison at the individual level rather than
on the group level as seen in RCT. Since each subject receives both interventions
and thus acts as its own control, the number of subjects required to produce simi-
lar precision is reduced considerably compared to parallel group trials [Elbourne
et al., 2002]. Furthermore, this study design can eliminate biological variation,
since variation in repeated responses within a subject is usually smaller than that
seen between subjects. Also, the number of replicate 2-DE gels is reduced. In
contrast, it should be noted that a cross-over design mediates a risk of a carry-over
effect, occurring when the treatment given in the fist period has an effect that is
carried over in the subsequent treatment period [Elbourne et al., 2002]. However,
a wash-out period between the different treatments may reduce the effect of carry-
over. Another noteworthy aspect is the treatment period interactions, which may
introduce bias into the outcome of the study.
In nutritional studies, the metabolic changes caused by a dietary intervention are
often small and subtle when working with subjects who are generally healthy and in
metabolic homeostasis. In addition, the effect of a dietary treatment is often smaller
than the biological variation in metabolic responses between individuals [Rezzi et
al., 2007]. Factors like sex, age, genetic background, environment, health sta-
tus and lifestyle may contribute to this variability [Anderson and Anderson 2002;
Nedelkov 2008; Winkler et al., 2008]. Consequently, this poses a challenge for nu-
tritional experimental design when evaluating dietary effects in humans and care
should be taken to minimise this source of heterogeneity in a given study. One
way to cope with this variation is to conduct carefully controlled studies with de-
fined diets where each subject participate both in the control and the test group
i.e. cross-over study design. Furthermore, the criteria for selecting participants
are also of importance in terms of reducing inter-individual variation. Pre-study
screening of participants including measurements of biological parameters such as
body mass index, blood pressure and clinical measurements as blood lipid status
and glycaemia is essential for participant selection. Moreover, additional know-
ledge about the participants including age, habitual dietary and lifestyle habits may
contribute to the selection process. According to proteomic based biomarker dis-
covery, the biological variation may affect a given protein in a way that might
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enhance or degrade its performance as a biomarker. To date, the extent of the
inter-individual variability of protein expression remains unclear. One of the main
challenges in proteomic based nutritional research is to separate the changes in pro-
tein expression profiling induced by a well-determined food intervention from the
so-called confounding factors such as biological variability. Only few studies have
demonstrated the presence of inter-individual variability in different proteomes e.g.
plasma, platelets, monocytes, peripheral blood mononuclear cells, saliva, urine,
cerebrospinal fluid and liver [Hu et al., 2005; Nedelkov et al., 2005; Nedelkov
2008; Quintana et al., 2009; Winkler et al., 2008; Zerefos et al., 2006; Zhang et al.,
2006].
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4 Aim of the study
The overall objective of this PhD study was to investigate the impact of meal intake
on human plasma proteins assessed by proteomics. Both acute effects and long-
term effects were evaluated based on a single meal study and a human intervention
trial, respectively.
The specific aims of the study were:
• To examine the postprandial changes in the plasma proteome and lipid pro-
file of elderly healthy men after single meal intake of trout (marine based
feed) and poultry. Furthermore, it was warranted to investigate whether a
two-dimensional gel based approach was a valuable tool with respect to de-
tection of the postprandial induced changes in human plasma proteins (Paper
I).
• To investigate the long-term effects of a change in feeding regime of farmed
trout from marine origin to vegetable based diet on consumers health. The ef-
fects were assessed by measurements of plasma proteome profiles in healthy
adult males (Paper II).
• To study the extent of biological variation between subjects with respect to
protein abundance assessed by measurements of the plasma proteome pro-
files in healthy elderly men (Paper III).
5 Overview of experimental design
The experimental part of the present PhD thesis is based on a single meal study
and an intervention trial conducted in healthy elderly men. The results from these
studies are presented in the three enclosed papers (see appendix). The following
section will briefly describe the experimental design of the two human studies to
give an overview of the experiments, which have been addressed in the papers.
5.1 Single meal study
The single meal study was a randomised single-blinded dietary cross-over study
including five healthy men in the age of 54-70 years. In random order, the sub-
jects received three test meals with poultry (control), marine fed trout (high of n-3
PUFA) or vegetable fed trout (high of n-6 PUFA) separated by one-week of inter-
val. Blood was sampled before the meal intake (baseline), four times during the
postprandial phase (1.5, 3, 4.5 and 6 h after meal ingestion) and after 24 h (fas-
ting blood sample) for proteome analysis and MS-based identification of proteins
of interest as well as TAG analysis (see Figure 7 and 8). Details concerning the
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participants, the meal content and the methods are described thoroughly in paper I
and paper III.
Figure 7: Experimental design and methods conducted in the single meal
study.
Figure 8: Time line of single meal study. Blood was sampled before the meal
intake, four times during the postprandial phase following a 24 h fasting sample.
A standard lunch and dinner were served in order to control the macronutrient and
energy intake during the test day.
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5.2 Human intervention trial
The human eight week intervention trial was a three-grouped parallel randomised
study including 68 healthy men in the age of 40-70 years. Subjects were randomly
assigned to one of the three groups eating either one daily meal of trout fed by a
pure marine based diet, one daily meal of trout fed by a pure vegetable based diet
or a daily meal of poultry (control meal). Blood was collected at baseline (week 0)
and at the end of the intervention (week 8) for plasma proteome analysis and MS-
based identification of proteins of interest (see Figure 9). 30 of the 68 subjects
(10 from each intervention group) were randomly selected and their samples were
used for proteomic analysis. Details concerning the participants, the meal content
and the methods are described in paper II.
Figure 9: Experimental design and methods conducted in the human in-
tervention study.
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6 Main results and discussion
During the experimental work with human plasma from the single meal study and
the intervention study, various choices were made in the laboratory regarding sam-
ple processing and 2-DE with the aim of obtaining most stable and reliable plasma
profiles. Several steps in the proteomic procedure appear critical for and might
contribute to variation. Pre-analytical variables such as sample collection, storage
and handling may have profound effects on the composition of the plasma sample
and these could confound the proteomic data analysis. Therefore, it is important
to quantify the sources of variation inherent in the proteomic method and improve
them to the extent possible in order to reduce artefacts that could bias the results
and further obscure the detection of the dietary induced changes in the human
plasma protein profiles.
6.1 Preparation of human plasma samples
Sample preparation of plasma often includes addition of protease inhibitors (PI) in
order to preserve the protein population from proteolytic cleavage that otherwise
may result in artificial protein spots and loss of high molecular weight proteins
on the 2-DE gel. However, the use of PI is challenging since differences in 2-DE
patterns both with and without PI are documented. Schuchard and colleagues have
shown that several human plasma protein trains on 2-DE gels were shifted toward a
higher isoelectric point following addition of a PI cocktail [Schuchard et al., 2005].
In contrast, Hulmes et al. have demonstrated that inclusion of PI in plasma samples
improved sample qualities and gave reproducible results based on classical 2-DE
image analysis, 2D-PAGE quality scoring and enzyme immunoassay [Hulmes et
al., 2004]. Furthermore, samples without PI cocktail varied significantly from con-
trol samples. In the present study, the benefits versus drawbacks of inclusion of
PI described in the literature were balanced and it was decided not to use PI in the
preparation for the human plasma samples. In that connection, different initiatives
were taken during sample preparation to reduce proteolysis. Following the Hu-
man Plasma Proteome Project recommendations [Omenn et al., 2005], blood was
collected in vacutainers containing EDTA anticoagulant, whose chelating action
may be advantageous. Moreover, plasma was prepared directly after venipuncture
and the applied TCA protein precipitation as well as urea, thiourea and chaps in
the reswelling solution are useful for minimising proteolytic activity [Castellanos-
Serra and Paz-Lago 2002; Gorg et al., 2004]. Still, it must be kept in mind that
proteolysis will presumably occur, since it is rather difficult to completely inac-
tivate all proteases. Consequently, a number of spots on the 2-D gel may reflect
protein fragments as a result of proteolysis. However, according to the tables of
MS/MS based protein identification (paper I and II) this seems not to be the case.
On the basis of the mass spectrum and the experimental MW and PI compared to
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the theoretical values, it was indicated that only few (four out of 37) of the different
significant spots changing in abundance were fragments of the reported proteins.
Another variable such as temperature during blood centrifugation may affect the
plasma profiles since several handling procedures have been shown to influence
the proteome profiling [Hsieh et al., 2006; Hulmes et al., 2004]. The blood sam-
ples from the volunteers were centrifuged at room temperature, although protein
stability is better at lower temperatures, but his temperature was chosen to avoid
cold activation of platelets [Banks et al., 2005]. This is of high importance since
platelets play a central role in thrombosis, haemostasis and inflammation, which
are essential processes implicated in CVD [Gawaz et al., 2005] and of great impor-
tance when evaluating health beneficial effects of fish consumption. In the light of
the foregoing reflections, there is without doubt a need for standardising methods of
collection, processing, and storage of plasma samples to minimise the effect of pre-
analytical variables on plasma proteome profiling and be able to detect biomarkers
in an unbiased fashion.
6.2 Depletion of high abundant proteins
Multiple strategies have been used to simplify the plasma proteome due to the vast
disparity in protein abundance of human plasma [Kim and Kim 2007] in which re-
moval of high abundance proteins by immunoaffinity capture is increasingly being
recognised as the most effective sample preparation strategy for plasma proteomics
[de Roos 2008]. In that connection, a study by Whiteaker and colleagues, who
examined eight different pre-fractionation approaches of human serum, demon-
strated that immunoaffinity subtraction of the high abundant proteins was most
effective and reproducible [Whiteaker et al., 2007]. On the other hand, this method
is not free of troubles. In the present study, plasma was fractionated by use of the
commercial available IgY-12 proteome partitioning column from Beckman Coulter
which captures the 12 most abundant plasma proteins. The principal rationale for
using this immunodepletion strategy was to lower the detection limit on the 2-DE
gels and make the lower abundant proteins accessible to global proteome profiling,
since the majority of potential disease/health biomarkers may be present at ex-
tremely low concentrations in plasma. Although use of the IgY-12 column greatly
improved the resolution of the gels, the lower abundant proteins were still out of
reach and the identified proteins were mainly common plasma proteins involved in
blood key functions.
It is important to note that some of the identified proteins were IgY-target proteins
which should have been retained by the column, although it was expected that the
remaining amount of these proteins was proportional to their original amounts.
On the basis of this result and the fact that the column is used for all samples,
variations in column absorption efficiency may occur. Although the column could
deplete 100 samples according to the manufacturers product descriptions, it has
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been shown that after 25 samples the protein content of the flow-though fraction
increased suggesting decreased efficiency for retaining the high abundant target
proteins [de Roos et al., 2008]. Therefore, consistent depletion conditions may not
be guaranteed. To shed light on this matter, a linear regression analysis of nine
selected (four non-significant and five significant IgY-target spots from paper I was
conducted. The proteomic data of these nine spots was listed in order according to
the date that the sample was fractionated by the IgY-column. The regression slope
was found significant in seven (two non-significant and five significant IgY-spots
(636, 859, 936, 937 and 940) out of nine examined spots. Conclusively, these spots
are doubtful since a time dependent variation in column absorption efficiency is
indicated and the results of these spots should thus be interpreted with caution.
The potential loss of inadvertent capture of non-targeted proteins due to the ability
of high abundant proteins, like albumin, to act as carrier proteins [Desrosiers et al.,
2007; Elrick et al., 2006] is also of concern, since some minor proteins may pos-
sibly remain bound to the column and will be lacking in the flow-through fraction
loaded on the 2-D gel. This may remove potential biomarker candidates during
the depletion process. Huang et al. have addressed this concern by examining the
flow-through fraction and bound/eluted fraction after IgY-depletion. They found
that proteins identified in the bound/eluted fraction consisted mainly of the targe-
ted abundant proteins except for four non-targeted proteins [Huang et al., 2005].
Equivalent to that study, Tu and colleagues demonstrated that the bound fraction
associated with immunodepletion contained a number of non-targeted proteins [Tu
et al., 2010]. Taken together, in quantitative plasma proteomic studies based on
immunoaffinity capturing, it is important to keep in mind the risk of not only the
potential non-selective loss of protein candidates but also incomplete absorption
ability of the column as suggested by the present results.
6.3 Visualisation of spots
Silver staining is a frequently used approach for visualisation of protein spots on
the 2-D gel due to its positive features such as excellent sensitivity below one ng of
protein and relative low cost for reagents [Weiss et al., 2009]. In this study, proteins
were stained by use of silver staining as described in [Wulff et al., 2008] and the
excellent sensitivity was demonstrated in comparison with Sypro Ruby fluorescent
stain and Coomassie Brilliant Blue where silver staining clearly visualised most
spots on the 2-D gel. Thus, this staining technique increased the possibility to
visualise as many proteins of potential use as specific biomarkers. However, one of
the drawbacks by the stain is the limited linear dynamic range which is important,
since spot saturation effects impede normalisation and accurate quantifications of
spots. Moreover, gel-to-gel variations are not negligible due to several solution
changes and other carefully timed steps. In addition, fluorescence staining is an
attractive approach since it offers reliable quantification over a wide linear dynamic
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range combined with a high sensitivity of spot detection [Wu et al., 2005]. Yet, the
dyes are very expensive and a costly fluorescent scanner is required, which was not
available at the time the staining procedure took place.
6.4 Technical variation and the significance of the IgY-12 fractiona-
tion on the proteomic data
The number of replicates is often restricted in 2-DE studies due to labour and
cost. Biological replicates (different measurements within the same experimen-
tal group) and technical replicates (repeated measurements of the same biological
sample) can be used in proteomic studies. Reliable sample preparation and lots of
experience with 2-DE based proteomics ought to minimise the technical variation.
In this study biological replication was carried out which is better than technical
replication, if a limited number of gels can be made [Horgan 2007]. Furthermore,
if technical replicates were used, it will be occurring at the expense of biological
replication which is not recommendable [Horgan 2007].
It is important to shed light on the technical variation since high 2-DE reproducibi-
lity is an essential prerequisite for obtaining high quality data and further identify
potential protein biomarkers. For that reason, six technical replicate gels of IgY-12
fractionated plasma from a single subject were run according to the applied 2-DE
procedure to investigate the scope of the technical variation in data, i.e. the contri-
bution of the IgY-12 column (data not shown). The mean coefficient of variation
(CV) of all spots (921 spots, 6 gels) in the replicate dataset was 25% in which 45%
of all the spots had CV values less than 20%. Moreover, it was clearly seen that
spots with a high variation (> three fold changes) were primarily low spot volumes
or located in the blurred area of the gel (Fig. 10A). Furthermore, six gels of pooled
IgY-12 preparations of human plasma samples from the same subject as mentioned
before was run to illustrate to what extent the IgY-column contributes to variation.
Analysis of pooled IgY-12 plasma samples (dataset of 921 spots, data not shown)
resulted in a mean CV of 18% in which 69% of the spots had CV values less than
20%. In that connection, results from a former experimental variation study of a
single human plasma sample prepared eight times by top-6 high abundance protein
depletion following 2D DIGE reported that 50% of all spots had less than 10% CV
[Corzett et al., 2006]. By comparison, we could report that 11% of the total number
of spots in our replicate study had less than 10% CV. However, it should be noted,
that the DIGE technique reduces the inter-gel variations and thus overcomes the
limitation of traditional 2-DE since three samples are loaded on a single gel.
To get insights into the technical variation of spots distinctly separated on the 2-D
gel, 25 randomly picked spots of both large and small volumes were selected (Fig.
10B). The mean CV of the 25 spots was 11% (range CV 5-17%) in the replicate
gels. In addition, nine selected (four non-significant and five significant) IgY-target
spots identified in paper I had a mean CV of 12% and 7% in the replicate study
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Figure 10: Representative 2-DE gel from the replicate study. A: The spatial
distribution of spot volumes larger than three fold changes. B: The spatial distribu-
tion of 25 randomly selected spots.
and the pooled study, respectively. Based on the results presented above, it was
indicated that the IgY-12 column contributes to variation in the proteomic data,
however, only to a lesser extent and did therefore not contribute the main variation
in the data.
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6.5 Acute postprandial effects of trout and poultry
To give an overview of the main findings from the present PhD project, aim and
main results from the two human studies are summarised in Table 1. Firstly, we
aimed at examining the acute postprandial changes in the plasma proteome and
lipid profile of elderly healthy men after single meal intake of trout and poultry.
Furthermore, it was warranted to investigate whether the 2-DE based approach
was an applicable tool to detect the postprandial changes in plasma proteins. Since
most individuals spend a large portion of their daytime in the postprandial state, it
is essential to investigate how dietary components affect the biochemical and phy-
siological processes within the human body. In healthy subjects, n-3 LCPUFAs
have been reported to reduce the magnitude of the postprandial TAG response [Avi-
ram et al., 1986; Zampelas et al., 1994], but this was not demonstrated in the single
meal study (Fig.1, paper 1). The change in plasma TAG concentration following
intake of trout and poultry resulted in a bell-shaped postprandial response, which
is in congruence with previous findings [Callow et al., 2002; Heath et al., 2003;
Overgaard et al., 2008]. All subjects demonstrated well-controlled lipid homeosta-
sis which is an important reflection of their metabolic efficiency, but no significant
difference was observed between the two TAG responses. The amount of fat in the
test meal and the inter-individual variability in the response, probably caused by
differences in metabolism may be a contributing factor for the lack of TAG lower-
ing effect of trout compared to poultry. In contrast, single meal studies in healthy
subjects have demonstrated a reduced postprandial lipaemia following fish oil in-
take in comparison with a fat load primarily containing saturated fat [Aviram et al.,
1986; Zampelas et al., 1994]. However, the given fat loads were far greater than
those consumed in the present trout meal. Furthermore, it should be noted, that
only five subjects were included in the study but the applied cross-over design, in
which the different treatments are evaluated on the same subject, reduces the num-
ber of subjects required to produce similar precision compared to parallel design
[Elbourne et al., 2002].
After single meal intake of trout and poultry, we were able to detect postpran-
dial changes during 24 h in human plasma proteins (Table 1, paper I). By use
of fractionated plasma depleted of the top 12 abundant proteins, the resolution
of the 2-DE gel images was greatly improved which increased the possibility to
quantify the lower abundant proteins. Image analysis of silver stained 2-DE gels
resulted in the detection of 1157 spots separated according to charge and mole-
cular weight. Of these, a total of 17 spots were found to change significantly in
abundance in the postprandial state relative to baseline (pre-prandial state) after
either the trout or poultry meal. None of the spots changed in response to both
meals, which indicates that the two type of meals elicited different responses in
plasma. By comparison of trout and poultry at concurrent time points, 14 spots
were significantly changed. Based on mass spectrometry, the significant spots re-
flected proteins categorised to be involved in different biological processes as lipid
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transport, coagulation and complement cascade, acute phase response as well as
cofactor and vitamin metabolism. However, it should be noted, that some of the
significant changed spots were IgY-target spots, which should have been retained
by the column. Therefore, these proteins must be interpreted with caution. The
meal induced fold changes after trout and poultry intake relative to baseline (ta-
ble 1, paper 1) were small. Thus, one might speculate if the variation caused by
the IgY-column fractionation may have added substantially to these results. This
seems not to be the case since the meal induced fold changes of the significant
spots were higher than the CVs of the same spots in the replicate data set with the
exception of spot 750 (ficolin 3, a non-IgY- target protein) and 937 (haptoglobin,
an IgY-target protein). These spots had a higher CV% in the replicate data set and
the meal response of those two spots may be doubtful. Furthermore, significant
baseline variations in spot volumes of 859 and 923 was seen and the meal response
of trout compared to poultry of these spots shown in table 2 should be interpreted
with caution since the baseline variation may confould the shown meal effects.
The postprandial response of trout and poultry compared to baseline variations of
the non-significant spot 818 is shown in Fig.11. It is demonstrated that the post-
prandial response exceeded baseline variations in four out of five subjects in spite
of the postprandial change in spot volume was not signicant. Taken together, the
meal induced changes of the plasma proteins detected in the present study are true
and it is furthermore important to keep in mind that dietary compounds often have
a subtle, but relevant effects on biomarkers of health [de Roos and McArdle 2008].
Ficolin-3, a non-IgY-target protein, was found significant at time 6 h as well as
24 h after poultry intake compared to baseline (table 1 in paper I). This protein is
chosen as an example to illustrate the error structure of a significant non-IgY-target
protein due to the isoforms present, even though the CV of spot 750 was higher
in the replicate data compared to the postprandial induced changes. However, the
high CV was probably due to a very low spot volume in a single replicate gel. The
postprandial time course of the ficolin-3 isoforms, spot 750 and 745, is shown in
Fig. 12, in which a parallel and gradual decline in volume intensity of both spots is
seen. Despite the high risk of false positives in multiple testing [Biron et al., 2006],
the time course of these spots clearly indicates that the postprandial change was not
appeared by chance. This is supported by the fact that both isoforms decreased over
time, even though the earlier time points were not significantly changed, and the
affected pathway was also relevant according to meal intake.
A 2-DE based approach is powerful for the high resolution separation of proteins
in a complex mixture as plasma [Zimny-Arndt et al., 2009]. However, the major
limitation of the 2-DE gel based approach is the rather time consuming steps in-
cluding sample preparation, 2-DE, staining, image analysis, statistical analysis of
data and protein identification. The visualisation of proteins can be obtained by ap-
plication of various staining techniques as organic dye, silver stain, reverse stain,
fluorescent stain, radio-labelling and chemiluminescent stain [Patton 2002]. All
the 2-DE results from the enclosed papers are based on a sensitive silver staining
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Figure 11: The postprandial response of trout and poultry compared to
baseline variations of the non-significant spot 818 in subject 1-5. In four
out of five subjects, the postprandial response exceeded the baseline variations.
method, which detected several hundreds of proteins. However, it should be noted,
that the staining method has a restricted dynamic range and spot saturation may
thus appear [Ahnert et al., 2004; Patton 2002]. Consequently, this can give rise
to bias during baseline subtraction due to the biological variation in spot intensity
may exceed the detectable analytical staining range.
Statistical analyses of the 2-DE data in paper I included both univariate and multi-
variate data analysis. Multivariate PLS regression was used as an additional statis-
tical tool to reveal all possible proteins associated with meal induced changes. As
expected, there was a large overlap of selected spots when compared to the mul-
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Figure 12: The postprandial response of ficolin-3 isoforms. The postprandial
time course of spot 745 and 750 identified as ficolin-3 shows a parallel and gradual
decline in spot volume intensity. The insert shows the distribution of the two spots
on the gel.
tivariate method, but some spots were only significantly selected by use of PLS.
Thus, in order to find all relevant spots in the data analysis it is suggested to use
univariate statistics combined with multivariate methods [Jensen et al., 2008]. Con-
clusively, despite methodological limitations of the IgY-12 column and the 2-DE,
this proteomic approach has provided insigths into the effects of meal intake on
plasma proteins. A further understanding of the metabolic mechanisms of protein
targets of nutrients is important contributions to knowledge of food based outcomes
in terms of health and disease.
6.6 Long-term effects of trout fed a marine or a vegetable based feed
Reduced availability of wild fish is a major challenge for the aquaculture sector.
Therefore, different feeding regimes of plant origins are evaluated as alternatives
to fish bone meal and fish oil. However, the impact of a change in feed composi-
tion on human health is largely unknown. Thus, we secondly aimed at investigating
whether a change in feed composition of farmed trout affected health of consumers
assessed by plasma proteome analysis. A parallel eight week dietary intervention
study was conducted in adult males as described in paper II, in which subjects
consumed a daily meal of farmed trout raised either on pure marine diet or pure
vegetable diet, or a reference meal of chicken. Plasma proteins, depleted of the 12
high abundant proteins, revealed a total of 681 distinct separated high-quality spots
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visualised by silver staining. Based on delta spot volumes (baseline subtracted
spots), a total of 23 spots changed significantly in abundance when comparing the
three intervention groups of marine fed trout, vegetable fed trout and chicken. Of
these, 18 spots were identified by mass spectrometry and the proteins were linked
to the various biological processes haeme transport and catabolism, regulation of
vasoconstriction, blood haemostasis, complement cascade, antioxidative defence,
cellular component movement, glycolysis and vitamin transport (Table 2, paper
II). Nine spots were significantly changed in abundance after intake of marine fed
trout compared to chicken and ten spot after intake of vegetable fed trout com-
pared to chicken. Two of the affected spots were changed after both types of trout
meals. Only a single spot identified as complement c1r was increased in the group
consuming the vegetable fed trout compared to the marine fed trout. This pro-
tein is involved in the complement system which is a major component of host
defence. The system initiates a cascade of highly regulated activation steps cul-
minating in the membrane attack complex resulting in cytolysis [Porter and Reid
1978]. However, inappropriate activation of the complement system can also con-
tribute to inflammation seen in various pathological conditions [Morgan and Harris
2003]. This finding is of significance since inflammation plays a central role in the
development of atherosclerosis. Indeed, if future replacement of fish oil with ve-
getable oils becomes inevitably, it is important to know more about the nutritional
consequences of such replacement for the consumer. From a nutritional point of
view, vegetable oils rich in ALA would be of choice in feed for farmed trout, since
salmonids are capable of converting ALA to its more biological active forms of n-3
PUFA, EPA and DHA [Sargent and Tacon 1999].
6.7 Inter-individual variation
The biological variation of the human population is a major obstacle in clini-
cal studies and biomarker discovery. Factors like sex, age, genetic background,
health status and lifestyle may contribute to this variability [Anderson and Ander-
son 2002; Nedelkov 2008; Winkler et al., 2008]. Proteomic studies need to address
the biological variation in protein expression between individuals in the general
population before application of biomarkers in clinical research. This variation
between individuals may influence the protein in a way that might enhance or de-
grade its performance as a biomarker. To date, the knowledge of the quantitative
differences in plasma protein expression across the general population is limited
and only few studies have investigated the inter-individual variability of different
proteomes. Hence, the need for a better understanding within this research field
is urgently needed. Thus, we thirdly aimed at investigating the extent of the bio-
logical variation between subjects with respect to protein abundance assessed by
measurements of the plasma proteome profiles in healthy elderly men. By use of
the 2-DE data set (a total of 483 distinct separated high-quality spots) from the sin-
gle meal study following applications of multivariate methods, PCA and PLSR, we
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revealed the individual differences between subjects (paper III). Multivariate data
analysis is a valuable tool since it offers a strong approach for evaluation of 2-DE
based protein profiles to get an overview of the main variation and structure in data
[Jensen et al., 2008; Karp and Lilley 2007]. PCA analysis was performed to get an
overview of how the experimental parameters including fasting versus postprandial
sampling, meal type, sampling week and subject contributed to the main variation
in the data set (Fig.1, paper III). Results from the PCA scores plot revealed that the
variation between subjects represented the largest variance component exceeding
the other measured experimental parameters. By use of PLS regression of the total
proteome data set (Table 1, paper III), a large number of spots were demonstrated
to be differentially expressed between subjects. Furthermore, analysing the data
with a longitudinal approach revealed an effect of the meals. PCAs on the sub-
jects one by one showed that postprandial samples taken after intake of the trout
fed a vegetable based feed grouped separately from samples taken after intake of
the other two meals (Fig.2, paper III). In four of five subjects there was a grou-
ping according to meal, however, of different extent (distance between groups) in
the subjects. Due to the detection of the significant IgY-target spots shown in pa-
per I, it is essential to examine whether the IgY-12 column may have added the
present results concerning the groping of samples due to individual variation. The
distribution of the known IgY-target spots was examined and they were found to
be randomly distributed in the loading plot from the PCA analysis of the experi-
mental parameters (Fig.1 paper III) and also in the PCA loading plot of the spots
that were differentially expressed between subjects (Fig.4, paper III). Furthermore,
excluding the IgY-target spots from the data matrix resulted in the similar and clear
grouping of the individuals in the PCA scores plot. Conclusively, these results
indicate that the IgY-12 fractionation has not contributed to the present results con-
cerning inter-individual variability.
The inter-individual variability can of course not be avoided but has to be taken into
consideration in the experimental study design, analytical proteomic strategy and
interpretation of the obtained results. Many authors have acknowledged the inter-
individual variability in humans, however, the extent of variation remains unclear
and is an important factor to try and quantify. From the results achieved in paper III,
we have demonstrated that cross-over studies using an individual as its own control
and measure analyte variations over time is an important experimental design for
studying human plasma proteins due to large biological variation between indivi-
duals. In this regard, these findings contribute to the further understanding of the
human proteome variability improving the biomarker discovery process being able
to discover new biomarkers that reflect early functional changes of importance.
Biomarkers measured in homeostatic perturbations such as challenge test may be
more valuable compared to the same biomarkers based on homeostatic condi-
tions (fasting state) [van Ommen et al., 2009]. We obtained perturbations with
a metabolic challenge in the human body in the form of a meal following post-
prandial measurements (the single meal study). This is a highly relevant challenge
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since much of the 24 h day is spent in the non-fasting state. The value of challenge
test is demonstrated in a recent cohort investigation, the Womens Health Study,
examining the fasting compared to non-fasting TAG levels in relation to CVD risk
[Bansal et al., 2007]. Postprandial plasma TAG was shown to be associated with
increased cardiovascular events while the fasting TAG showed little relationship.
Thus, postprandial measures may be more robust indicators of disease risk and
the great variability of postprandial levels between individuals provides important
information about an individuals metabolism. However, these challenge tests war-
rant further investigations as indicators of the metabolic state to detect the accurate
disease risk.
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7 Conclusions
Based on the 2-DE proteomic investigation of dietary induced changes in the hu-
man plasma profiles from the single meal study and the intervention study, we
conclude that:
• Consumption of single meals of poultry or trout elicited acute postprandial
changes in abundance of several plasma proteins implicated in the different
biological processes lipid transport, complement and coagulation cascade,
acute phase response as well as cofactor and vitamin metabolism. Intake
of trout and poultry elicited no differences in the postprandial bell-shaped
TAG response. A 2-DE based approach, however in refined ways, may be a
valuable tool with respect to detection of the postprandial induced changes
in human plasma proteins.
• An eight week dietary intervention with chicken and trout fed either a ma-
rine based feed or a vegetable based feed revealed a change in abundance
of plasma proteins involved in the biological processes haeme transport and
catabolism, regulation of vasoconstriction, blood haemostasis, complement
cascade, antioxidative defence, cellular component movement, glycolysis
and vitamin transport. Furthermore, the change in feed composition of trout
had a lower impact on the plasma protein profiling in contrast to the diffe-
rences in response after intake of trout compared to chicken.
• The inter-individual variability represented the largest observed variance com-
ponent exceeding fasting or postprandial sampling, meal type (poultry, ma-
rine and vegetable fed trout) and sampling week). Thus, the inter-individual
variability is a significant factor for comparative proteomic studies and needs
to be taken into account in the experimental design of human studies and in-
terpretation of data. Furthermore, cross-over design in which each individual
acts as its own control and longitudinal sampling on the basis of a physio-
logical challenge (e.g. meal intake) seems more informative than parallel
study design.
These conclusions are summerised in Figure 13.
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Figure 13: Overview of conclusions. B = baseline, P = poultry, M = marine
fed trout and V = vegetable fed trout.
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8 Future perspectives
This thesis has contributed to the clarification of several research questions and
concurrently generated new issues and perspectives, which require further investi-
gation.
In relation to diet induced changes in human plasma proteins, we need to increase
our understanding of the underlying molecular mechanisms that are in play to im-
prove health and prevent the onset of disease. We have shown a measurable effect
on a number of proteins implicated in various pathways of importance for chronic
disease such as CVD. A further understanding within this research field will have a
large impact on public health. Specifically, development of proteomic tools based
on the identification of new plasma proteomic biomarkers that identify metabolic
changes in specific tissue and organ is needed to clarify the complex mechanisms
of action. These novel biomarkers, compared to already known risk markers, will
allow early detection of the onset of disease or, ideally, the pre-disease state.
In the present study, we have examined the impact of mixed meals on human
plasma proteins. The effects of single nutrient components, protein, lipid and car-
bohydrate and their interactions on metabolism will be interesting to investigate. In
future nutritional studies, we should focus on the experimental design to increase
the sensitivity of detecting and identifying biological changes related to dietary
induced health effects. We have demonstrated that cross-over studies using an in-
dividual as its own control and measure analyte variations over time are a very
sensitive experimental design.
Based on the results from the dietary intervention study with differently fed trout,
new studies should be performed to further evaluate the influence of the change in
feeding regimes for farmed trout in relation to the nutritional properties of the fish
especially with focus on n-3 LCPUFA content. This is an important issue to clarify
due to the well-documented beneficial effects of these fatty acids.
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Lessons learned
Based on 2-DE proteomics, we were able to detect and identify a number of po-
tential candidate proteins in human plasma that were affected after intake of trout
compared to poultry both according to acute and long-term effects. The candi-
date proteins are related to pathways involved in transportation of food compo-
nents, lipid modulating processes, immune function and anti-oxidative defence.
The present approach, though optimised with respect to methodology and design
offers a potential for revealing nutritional biomarkers, also supported by the fact
that proteins found significant in the present study are involved in likely pathways
related to dietary consumption.
During the work with plasma proteomics, several barriers were encountered in-
cluding the extreme dynamic range of plasma proteins spanning at least ten orders
of magnitude and the resulting requirement for fractionation to reveal even a mo-
dest number of proteins. Depletion of the high abundant proteins, which comprise
the vast majority of total protein mass, greatly improved the resolution of the gels,
but the lower abundant proteins were still out of reach. However, in quantitative
plasma proteomic studies based on immunoaffinity capturing, it is important to
keep in mind the risk of not only the potential non-selective loss of protein can-
didates but also incomplete absorption ability of the column as suggested by the
present results. Furthermore, the present 2-DE approach has limitations. 2-DE is
laborious due to multiple analytical steps which may increase the risk of bias. Gel
to gel variations often occurs and the applied silver staining has a limited dynamic
range. Moreover, multiple testing increases the risk of false positives. On the con-
trary, 2-DE enable the simultaneous analysis of hundreds of proteins, access to
posttranslational modifications and a relative quantification on the 2-DE images.
Pre-analytical factors such as sample collection, storage and handling as well as
analytical factors can have profound effects on the outcome of a discovery study.
In addition, the biological variation of the subjects may also contribute to bias. One
way to cope with this inter-individual variation is to conduct carefully controlled
studies e.g. cross-over studies, in which each subjects participate both in the con-
trol and test group, due to the variation within a subject is usually smaller than that
seen between subjects.
Clearly, proteomics studies do not lead to biomarkers that directly can be applied
in clinical diagnostics; the journey from discovery to practical implementation in
clinical diagnostics is still long and uncertain. 2-DE based proteomics should be
considered as a screening tool that offers a well-established approach to find new
biomarkers of plasma - the circulating representation of all body tissue and thus the
most comprehensive human proteome. These candidate proteins must be further
verified and validated in large-scale studies required to determine the key para-
meters for diagnostics test such as biological variability, sensitivity and specificity
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according to target state, and the contribution in various multi biomarker panels
[Anderson 2005b]. Despite the high potential of plasma proteomics for biomarker
discovery and vast amount of intensified research and investment, a paradoxically
decline is observed in the number of new biomarkers approved for clinical diagnos-
tics [Anderson and Anderson 2002]. The reason for the shortage of new biomar-
kers is probably related to the high false discovery rate of biomarkers in proteomics
technologies arisen from biological and technical variability in combination with
a lack of robust methods for biomarker verification in clinical large sample sets
[Anderson 2005; Rifai et al., 2006; Carr and Anderson 2008]. Currently, there is
no ideal, extensive biomarker discovery platform for plasma proteomics. A stan-
dard biomarker pipeline is urgently needed that relieves the bottleneck between
biomarker discovery and clinical validation.
The emerging technology of mass spectrometry targeted protein quantification has
increasingly becoming important for biomarker development in clinical research
[Pan et al., 2009; Anderson 2005]. The absolute quantification relies on the use
of stable isotopes labelled reference peptides/proteins which acts as internal stan-
dards, enabling protein quantification by comparing the signals from the exoge-
nously labelled and the corresponding unlabelled peptide. In a recent study, mass
spectrometry-based multiple reaction monitoring of proteins revealed the absolute
quantification of 45 endogenous proteins in human plasma based on trypsin di-
gests without prior affinity depletion or enrichment [Kuzyk et al., 2009]. Future
proteomics technologies should to be able to detect biomarker candidates in the
presence of high abundance proteins to avoid depletion of candidate proteins due
to non-specific binding to high abundant proteins. Development of standard, robust
sample preparation strategies and more sophisticated technologies like the targeted
MS methods in combination with novel data processing methods are expected to
provide a smoother path from science to practice than exists today.
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